Ingelfinger

In·gel·fin·ger

(ing-gel-fing'gĕr),
Franz, U.S. nephrologist and editor, 1910-1980. See: Ingelfinger rule.
References in periodicals archive ?
Heidenreich, chief executive officer; Jesper Andersen, executive board member, finance and quality; Stefan De Loecker, executive board member, Near East and Americas; Ralph Gusko, executive board member, consumer brands and Asia Pacific; Thomas Ingelfinger, executive board member, Europe; Zhengrong Liu, executive board member, human resources and corporate communications; Vincent Warnery, executive board member, pharmacy and selective.
Abott WO, Hartline HK, Hervey JP, Ingelfinger FJ, Rawson AJ, Zetzel DL.
Julie R Ingelfinger, Kamyar Kalantar-Zadeh, Franz Schaefer; en nombre del Comite Directivo del Dia Mundial del Rinon *
Hoy WE, Ingelfinger JR, Hallan S, Hughson MD, Mott SA, Bertram JF.
Ingelfinger, "Preemptive olmesartan for the delay or prevention of microalbuminuria in diabetes," The New England Journal of Medicine, vol.
The Ingelfinger Rule: Franz Ingelfinger at the New England Journal of Medicine 19671977.
But benefits could be a long way off, Clifford Rosen of the Maine Medical Center Research Institute in Scarborough and Julie Ingelfinger of Massachusetts General Hospital write in an editorial accompanying the paper.
Listening attentively to patients' presentations and noting special concerns underlying patients' narratives (Mishler, Clark, Ingelfinger, & Simon, 1989)
These embargo policies are an artifact of the so-called Ingelfinger Rule, which states that scholars should not publish the same article in multiple venues (Jacobsmeyer, 2012).
Julie Ingelfinger is the senior consultant in pediatric nephrology at the Massachusetts General Hospital in Boston.
Ingelfinger (17), refiere en su editorial que el BPN aumenta el riesgo de problemas en la adultez temprana como hipertension arterial, enfermedad cardiovascular, diabetes mellitus tipo 2.